Mary Lynne Hedley

TESARO Inc (NASDAQ: TSRO) shares opened 3.25 percent higher after being halted around 3:30 p.m. ET. The company announced FDA approval of niraparib and plans to initiate registration processes for expanded indications of metastatic ovarian, breast and lung cancers. As of yet, niraparib supports...